DBV TECHNOLOGIES
associated with 11 other trademarks
adhesive patches enabling cutaneous or epicutaneous administration of powdered medicated or pharmaceutical substances for humans or animals featuring ...

Words that describe this trademark:

pharmaceutical substances  adhesive device  humans animals  device  enabling  administration  medicated  substances  powdered  cutaneous 

Serial Number:

79251242

Mark:

DBV TECHNOLOGIES

Status:

Registered

Status Date:

07-23-2019

Filing Date:

Registration Number:

5809654

Registration Date:

07-23-2019

Goods and Services:

adhesive patches enabling cutaneous or epicutaneous administration of powdered medicated or pharmaceutical substances for humans or animals featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases; drug delivery patch containing a preparation in powder form for medical use for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusive patch enabling the cutaneous absorption of a powdered medicated substance featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases medical apparatus, instruments and devices for the cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans or animals, namely, drug delivery patches sold without medication; occlusive dispenser for medical use sold without medication; medical instrument using electrostatic properties from a biocompatible support, namely epicutaneous patches sold without medication research in the field of immunotherapy; design of a scientific method for epicutaneous desensitization via immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of processing and treatment of allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin, other than simple and light cleaning in order to leave the cell structure of the skin intact, thus avoiding the transfer of the allergen into the blood; drug discovery being scientific research and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; design of methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact medical services applying a method for desensitizing by immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases via allergen administration by placing a patch on the patient's intact skin while preventing the allergen from getting into the blood; medical treatment of allergies, inflammatory and autoimmune diseases using a method for desensitizing by epicutaneous immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases by epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to combat allergies

Mark Description:

The mark consists of the wording a "DBV TECHNOLOGIES" in black and a design comprised of two gray concentric circles above a cyan curved line. White is not claimed as a feature of the mark and represents background or transparent areas, only.

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

05-07-2019

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

N/A

Business Name:

MARIE-ANDREE

Correspondent Name:

Recent Trademark filings by this company